Rewriting quality system for a multinational biotech company

imThis customer is a US-based multinational biotechnology company specializing in design and manufacture of laboratory instruments, equipment and software. They employ 50,000 people and in 2013 they reported revenues of over $13 billion.


About the Project

The company is undertaking a significant process improvement initiative that will include a complete rewrite of the Life Sciences Mass Spectrometry Systems area’s quality system. They have asked IMUS to

  • perform a content audit of their operating procedures
  • optimize the architecture of the content, and
  • create document templates that will support implementation of the optimized architecture.

This project will require IMUS consultants to review and reengineer over 400 pages of operating procedures documentation.